Immunobiochemical profile of clear cell renal cell carcinoma (ccRCC): A preliminary study

被引:2
|
作者
Vargova, Daniela [1 ,6 ]
Dargaj, Jan [2 ,3 ]
Franova, Sona [1 ]
Dohal, Matus [4 ]
Luptak, Jan [2 ,3 ]
Svihra, Jan [2 ,3 ]
Bris, Lukas [2 ,3 ]
Grendar, Marian [5 ]
Sutovska, Martina [1 ]
机构
[1] Comenius Univ, Jessenius Fac Med Martin, Dept Pharmacol, Martin, Slovakia
[2] Comenius Univ, Jessenius Fac Med Martin, Dept Urol, Bratislava, Slovakia
[3] Univ Hosp Martin, Martin, Slovakia
[4] Comenius Univ, Jessenius Fac Med Martin, Biomed Ctr Martin, Martin, Slovakia
[5] Comenius Univ, Jessenius Fac Med Martin, Biomed Ctr Martin, Bioinformat Unit, Martin, Slovakia
[6] Comenius Univ, Jessenius Fac Med, Dept Pharmacol, Martin, Slovakia
关键词
Renal cell carcinoma; Cytokines; STAT3; Tumor; Immune system; ENDOTHELIAL GROWTH-FACTOR; PROTEIN; 10; IP-10; GM-CSF; GENE-EXPRESSION; CANCER; STAT3; SURVIVAL; ACTIVATION; CHEMOKINES; APOPTOSIS;
D O I
10.4149/gpb_2023015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Clear cell renal cell carcinoma (ccRCC) is the most common variant of RCC. It is an aggressive disease with an unfavorable prognosis. The rich immune infiltrates present in the tumor microenvironment (TME) of ccRCC produce various signaling molecules, especially cytokines, which primarily activate the Jak/STAT pathway and significantly influence tumor pathogenesis. STAT3 has a well-defined oncogenic character. Using multiplex assays and ELISA, we have measured the concentrations of 27 cytokines and STAT3 in tumor and healthy renal tissue from 16 patients with histologically verified ccRCC. We have detected significantly higher levels of G-CSF, IL-6, CXCL10, CCL3, and CCL4 in tumor tissue than in their healthy counterparts. There were significant differences in the levels of IL-1 beta and PDGF-BB between tumors of different nuclear grades (NG). Intra-tumoral IL-12p70 and IL-15 showed a significant positive correlation with intratumoral STAT3. The concentration of STAT3 in tumors was significantly lower than in the kidney. An increase in tumor STAT3 levels was associated with an increase in the pathological stage of the disease (TNM), but not with NG. The results of our study confirm the significant role of various cytokines and STAT3 in the pathogenesis of ccRCC and indicate their clinical relevance.
引用
收藏
页码:387 / +
页数:16
相关论文
共 50 条
  • [1] The lipid metabolomic profile of clear cell renal cell carcinoma (CCRCC)
    George, S.
    Choi, K-S
    Miecznikowski, J.
    Pili, R.
    Kazim, A. L.
    BJU INTERNATIONAL, 2012, 110 : 15 - 16
  • [2] The lipid metabolome of clear cell renal cell carcinoma (CCRCC).
    George, Saby
    Choi, Kyoung-Soo
    Pili, Roberto
    Kazim, Abdul Latif
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Immune expression profile and sunitinib benefit in metastatic clear cell renal cell carcinoma (ccRCC)
    Reig Torras, O.
    Marin-Aguilera, M.
    Jimenez, N.
    Pare, L.
    Galvan, P.
    Mallofre, C.
    Prat, A.
    Mellado Gonzalez, B.
    ANNALS OF ONCOLOGY, 2017, 28
  • [4] A study on the expression of ITGA5 on clear cell renal cell carcinoma (CCRCC)
    Linares, E. M.
    Leon-Castillo, A.
    Marcos Gonzalez, S.
    de Leon Rivas, C.
    Bueno Ortiz, P. M.
    Racean, S. F.
    Herrero Blanco, E.
    Garcia Arranz, P.
    Freire Salinas, J.
    Azueta Etxebarria, A.
    Gomez-Roman, J.
    VIRCHOWS ARCHIV, 2017, 471 : S283 - S284
  • [5] Prognostic biomarkers in patients with clear cell renal cell carcinoma (ccRCC)
    Gandur Quiroga, Maria N.
    Knott, Maria E.
    Pulero, Carla
    Pasik, Leonardo
    Alvarez, Ana M.
    Brzezinski, Mariano
    Malagrino, Hector
    Bal de Kier Joffe, Elisa D.
    Puricelli, Lydia I.
    CANCER RESEARCH, 2012, 72
  • [6] Expression of erythropoietin and neuroendocrine markers in clear cell renal cell carcinoma (CCRCC)
    Mjones, P.
    Nordrum, I.
    Qvigstad, G.
    Sordal, O.
    Rian, L. L. Martensson
    Waldum, H. L.
    VIRCHOWS ARCHIV, 2017, 471 : S283 - S283
  • [7] Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics
    Zhang, Sihong
    Xu, Xianglai
    Wang, Yelin
    Zhu, Yanjun
    Wang, Jiajun
    Wang, Hang
    Guo, Jianming
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2021, 51 (05): : 597 - 608
  • [8] Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues
    Vieira de Ribeiro, Ana Julia
    Sandim, Vanessa
    Ornellas, Antonio Augusto
    Reis, Rodrigo Siqueira
    Domont, Gilberto
    Alves, Gilda
    INTERNATIONAL BRAZ J UROL, 2013, 39 (01): : 83 - 94
  • [9] Novel biomarkers and therapeutic targets in clear cell renal cell carcinoma (ccRCC)
    Meseguer Navarro, Anna
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 17 - 18
  • [10] Transcriptional (mRNA) Profiling in Clear Cell Renal Cell Carcinoma (CCRCC): Comparison of CCRCC to Non-Neoplastic Renal Tissue
    Bastacky, S. I.
    Bastacky, M. L.
    Roy, S.
    Parwani, A. V.
    Dhir, R.
    Lyons-Weiler, M. A.
    Sciulli, C. M.
    Krill-Burger, M.
    Amin, M.
    LaFramboise, W. A.
    LABORATORY INVESTIGATION, 2013, 93 : 196A - 196A